Список литературы

31. Kneyber MCJ. Hematologic Emergencies in the PICU. Pediatric Critical Care Medicine. 2014 May 28:287–96. doi: 10.1007/978-1-4471-6416-6_20. PMCID: PMC7122033.

32. Александрович Ю.С., Пшениснов К.В. Современные принципы диагностики и интенсивной терапии септического шока у детей// Росс.вестник детской хирургии, анестезиологии и реанимации, 2011.-№3.-С.31-35.

33. Лабораторная диагностика менингококковой инфекции и гнойных бактериальных менингитов: Методические указания. –МУК 4.2.1887-04.

Annals of Intensive Care 2013, 3:12 doi:10.1186/2110-5820-3-12.

35. De Jong A. van Oers, J.A. et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial// The Lancet Infectious Diseases. - 2016. - №7. – P. 1-9

36. Charles P.E, Ladoire S., Aho S.Serum procalcitonin elevation in critically ill patients at the onset 128 of bacteremia caused by either Gram negative or Gram positive bacteria.//BMC Infect Dis. 2008; 8:38.

37. Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire  FilmArray®meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect 2020;26:281-90. doi: 10.1016/j.cmi.2019.11.016

38. Trujillo-Gómez J, Tsokani S, Arango-Ferreira C et al. Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta-analysis. EClinicalMedicine. 2022 Feb 14;44:101275. doi: 10.1016/j.eclinm.2022.101275. PMID: 35198914; PMCID: PMC8851290. 

39. Posnakoglou L et al. Impact of cerebrospinal fluid syndromic testing in the management of children with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2379-2386. doi: 10.1007/s10096-020-03986-6.

40. Cailleaux M, Pilmis B, Mizrahi A et al.  Impact of a multiplex PCR assay (FilmArray®) on the management of patients with suspected central nervous system infections. Eur J Clin Microbiol Infect Dis. 2020 Feb;39(2):293-297. doi: 10.1007/s10096-019-03724-7.

41. van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.// Clin Microbiol Infect. 2016; 22 Suppl 3:S37-S62. doi:10.1016/j.cmi.2016.01.007

42. Guiducci S, Moriondo M, Nieddu F, Ricci S, De Vitis E, Casini A, et al. (2019) Culture and Real-time Polymerase Chain reaction sensitivity in the diagnosis of invasive meningococcal disease: Does culture miss less severe cases? /PLoS ONE,-2019.-14(3): e0212922.

43. Malley R. et al.  Cerebrospinal fluid pleocytosis and prognosis in invasive meningococcal disease in children, The Pediatric Infectious Disease Journal: October 1998 - Volume 17 - Issue 10 - p 855-859

45. Остапенко Б.В., Войтенков В.Б., Марченко Н.В. и др. Современные методики мониторинга внутричерепного давления// Медицина экстремальных ситуаций.-2019.-21:4.-С.472-785

46. Васильева Ю.П., Скрипченко Н.В., Вильниц А.А. Ультразвуковое исследование в диагностике и мониторинге поражения оболочек мозга при нейроинфекциях у детей (менингит, менингоэнцефалит) // Медицина экстремальных ситуаций. 2017. №1 (59).

47. Sarnaik, A.P., Sanfilippo, D.J. & Slovis, T.L. Ultrasound diagnosis of adrenal hemorrhage in meningococcemia. Pediatr Radiol 18, 427–428 (1988).

48. Littwin B, Pomiećko A, Stępień-Roman M, Spârchez Z, Kosiak W. Bacterial meningitis in neonates and infants - the sonographic picture. J Ultrason. 2018;18(72):63-70.

49. Singh J, Himanshu D, Nim RK, Dinkar A, Gupta KK. Meningitis with Digital Gangrene in Meningococcal Infection: An Atypical Presentation. J Clin Diagn Res. 2016;10(12):OD03-OD04. doi:10.7860/JCDR/2016/22206.9017

50. Fonseca Y, Tshimanga T, Ray S, et al. Transcranial Doppler Ultrasonographic Evaluation of Cerebrovascular Abnormalities in Children With Acute Bacterial Meningitis. Front Neurol. 2021;11:558857.

51. Joffe AR. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Int Care Med 2007;22:194-207.

52. Engelborghs S, Niemantsverdriet E, Struyfs H, et al. Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst). 2017;8:111-126.

53. Войтенков В.Б., Вильниц А.А., Климкин А.В., Скрипченко Н.В., Конев А.И., Иванова Г.П. Клинические и нейрофизиологические особенности полиневропатии критических состояний у детей с инфекционными заболеваниями // Медицина экстремальных ситуаций. 2015. №2 (52)33-37

54. Nadel S. Treatment of Meningococcal Disease // Journal of Adolescent Health.-2016.- 59  S21-28.

55. Abdelhamid A.S., Loke Y.K., Abubakar I., Song F. Antibiotics for eradicating meningococcal carriages: Network meta-analysis and investigation of evidence inconsistency//World J Meta-Anal. Aug 26, 2016; 4(4): 77-87

56. National Center for Biotechnology Information. PubChem Compound Summary for CID 135398735, Rifampicin. https://pubchem.ncbi.nlm.nih.gov/compound/Rifampicin. Accessed Dec. 2, 2021.

57. Государственный реестр лекарственных средств. [Internet]. http://grls.rosminzdrav.ru.

58. Регистр лекарственных средств России [Internet]. https://www.rlsnet.ru/mnn_index_id_216.htm

59. Zalmanovici T., Fraser A, Gafter-Gvili A. et al. Antibiotics for preventing meningococcal infections. //Cochrane Database of Systematic Reviews, 2013, Issue 10.- Art. No.: CD004785.  

60. Prasad K.Karlupia N, Kumar A. Treatment of bacterial meningitis: An overview of Cochrane systematic reviews //Respiratory Medicine .-2009.-V.-103.-P.945-950. 

61. Sudarsanam TD, Rupali P, Tharyan P. et al. Pre-admission  antibiotics for suspected cases of meningococcal disease. Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD005437. doi: 10.1002/14651858.CD005437.pub4.

62. Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD004405.

63. BernardoWM, AiresFT, Sá FP. Effectiveness of the association of dexamethasone with antibiotic therapy in pediatric patients with bacterial meningitis. Rev Assoc Med Bras. 2012;30:586-593.(http://www.wfpiccs.org/education/doctors-nurses/documents/#_blank)

64. Brouwer M., Mcintyre P.et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev.-2010.CD004405[4]

65. Mathur NB, Gard A, Mishra TK.Role of dexamethasone in neonatal meningitis: a randomized controlled trial. (http://www.wfpiccs.org/education/doctors-nurses/documents/#_blank)The Indian Journal of Pediatrics 2013; 80(2): 102–107.

66. Prats JA, GasparAJ, Ribeiro AB e al. Systematic review of dexamethasone as an adjuvant therapy for bacterial meningitis in children. Revista Paulista de Pediatria 2012; 30(4): 586-593.

67. Annane D, Bellissant E, Bollaert P, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No.: CD002243.

68. Menon K, McNallyD, Choong K et al. A systematic review and meta-analysis on the effect    of steroids in pediatric shock. Pediatric Critical Care Medicine 2013;14:474-480.

69. Maconochie IK, Bhaumik S. Fluid therapy for acute bacterial meningitis. // Cochrane Database Syst Rev. 2016;11(11):CD004786.

70. Lampin ME, Rousseaux J, Botte A, et al: Noradrenaline use for septic shock in children: Doses, routes of administration and complications. Acta Paediatr 2012; 101:e426–e430

71. Tourneux P, Rakza T, Abazine A, et al: Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants. Acta Paediatr 2008; 97:177–180108.

72. Ranjit S., Natraj R., Kandath S.K., et al. Early norepinephrine decreases fluid and ventilatory requirements in pediatric vasodilatory septic shock // Indian J Crit Care Med. 2016. Vol. 20. No. 10. P. 561– 569. DOI: 10.4103/0972-5229.192036

73. Permpikul C., Tongyoo S., Viarasilpa T., et al. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial // Am J Respir Crit Care Med. 2019. Vol. 199. No. 9. P. 1097–1105. DOI: 10.1164/rccm.201806-1034OC

74. Elbouhy M.A., Soliman M., Gaber A., et al. Early Use of Norepinephrine Improves Survival in Septic Shock: Earlier than Early // Arch Med Res. 2019. Vol. 50. No. 6. P. 325–332. DOI: 10.1016/j.arcmed.2019.10.003

75. Wen L., Xu L. The efficacy of dopamine versus epinephrine for pediatric or neonatal septic shock: A meta-analysis of randomized controlled studies // Ital J Pediatr. 2020. Vol. 46. No. 1. P. 1–7. DOI: 10.1186/s13052-019-0768-x

76. Russell J.A. Vasopressor therapy in critically ill patients with shock // Int Care Med. 2019. Vol. 45. No. 11. P. 1503–1517. DOI: 10.1007/s00134-019-05801-z

77. Wall EC, Ajdukiewicz KM, Heyderman RS et al. Osmotic therapies added to antibiotics for acute bacterial meningitis. Cochrane Database Syst Rev. 2013; CD008806

78. Santillanes G, Luq Q. Emergency Department Management of Seizures in Pediatric Patients. //EB Medicine. 2015;12(3):1-28.

79. Баранов А.А., Шайтор В.М., Глоба О.В. Клинические рекомендации (протокол) по оказанию скорой медицинской помощи при судорогах у детей /Клинические рекомендации.Скорая медицинская помощь под ред.С.Ф.Багненко.-2020.-ГОЭТАР-Медия.-С.766-772

80. Serednyakov K., Lobzin Y. Extracorporeal hemocorrection in treatment of meningococcal septic shock in children. Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care.-2019.-V9. -P.35-40.

81. Forni LG, Ricci Z, Ronco C. Extracorporeal renal replacement therapies in the treatment of sepsis: where are we?// Semin Nephrol. -2015.-V.35.-P.55–63.

82. Foead AI, Mathialagan A, Varadarajan R, Larvin M. Management of symmetrical peripheral gangrene. Indian J Crit Care Med 2018;22:870-4

83. McNamara LA, MacNeil JR, Cohn AC, Stephens DS. Mass chemoprophylaxis for control of outbreaks of meningococcal disease. // Lancet Infect Dis. 2018.- 18(9):e272-e281.

84. Telisinghe, L.D., Waite, T.D., Gobin, M. Et al., Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review.// Epidemiology and Infection, 2015.-V.143.-P., 2259 - 2268.

85. Zalmanovici T.A, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev. 2013 Oct 25;2013(10):CD004785. doi: 10.1002/14651858.CD004785.pub5. PMID: 24163051; PMCID: PMC6698485.

86. Schwartz B. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections //Reviews of Infectious diseases. – 1991. – Т. 13. – №. Supplement_2. – С. S170-S173.

87. Gardner P. Clinical practice. Prevention of meningococcal disease. N Engl J Med. 2006 Oct 5;355

88. Strifler L, Morris SK, Dang V, Tu HA, Minhas RS, et al. The health burden of invasive meningococcal disease: a systematic review. J Pediatric Infect Dis Soc. 2016;5(4):417–30.

89. Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(2):1–28.

90. Позиция ВОЗ по менингококковым вакцинам. / Еженедельный эпидемиологический отчет. Т.86 (№47). ― М., 2011. ― С. 521–540.

91. СанПиН 3.3686-21 "Санитарно-эпидемиологические требования по профилактике инфекционных болезней"

92. Методические рекомендации по иммунопрофилактике менингококковой инфекции у детей. СОЮЗ ПЕДИАТРОВ РОССИИ Методические рекомендации 2-е издание, переработанное и дополненное. Москва 2019;